Last reviewed · How we verify

NCT07016594

Acute Cardiovascular Responses to Two Types of Exercise

Completed NA Last updated 15 June 2025
What this trial tests

NA trial testing Aerobic exercise in Aerobic Exercise in 20 participants. Completed in 1 June 2023.

Timeline
25 January 2022
Primary endpoint
1 June 2023
1 June 2023

Quick facts

Lead sponsorUniversity of Manitoba
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment20
Start date25 January 2022
Primary completion1 June 2023
Estimated completion1 June 2023
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Manitoba

Who can join

Adults 18 to 30, any sex, with Aerobic Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research was to explore potential differences in acute cardiovascular responses between two conditions: 1) moderate-intensity cycle ergometer exercise; and 2) moderate-intensity cycle ergometer exercise with NMES. Young, healthy, physically active participants were recruited for this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aerobic exercise

Trials testing the same drug.

Other recruiting trials for Aerobic Exercise

Currently open trials in the same condition.

Other University of Manitoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing